Objective: In the present study, we compared the results of conventional ultrasonography (US) and colour flow Doppler sonography (CFDS) with those of US guided fine needle aspiration biopsy (FNAB) and of pathologic staging of resected thyroid nodules, to assess the relative importance of US and CFDS in discriminating malignant thyroid nodules. Subjects and Study Design: We retrospectively reviewed records of 230 patients submitted to US-guided FNAB before surgery for solitary, not hot thyroid nodules. Before US guided FNAB, they were examined with conventional US and CFDS. Conventional US evaluated nodule size, echogenicity, presence of halo sign and microcalcifications. CFDS evaluated the vascular pattern classified as types I, II and III. Twenty-seven patients with inadequate cytology were excluded from this study (11.7%). Results: Two hundred and three patients underwent surgery. At histology a thyroid carcinoma was found in 36 patients (17.7%) and a benign nodule was observed in 167 patients (82.3%). We did not find any difference in cancer prevalence between nodules with a primary tumour size ≤1 cm and those >1 cm (17.6 vs. 17.7%; p = 0.99). A solid echo texture was not statistically significant to suggest malignancy (p = 0.32). Microcalcifications were seen in 83.3% (30/36) of malignant nodules and in33.5% (56/167) ofbenign nodules. These results were statistically significant (p < 0.0001). The type III flow as determined by CFDS was a statistically significant criterion to suggest malignant disease (p < 0.005). The most predictive findings of malignancy on conventional US was the combination of microcalcifications plus the absence of halo sign (sensitivity 75%, specificity 71.9%, p < 0.0001). The combination of an absence of halo sign on conventional US and a type III pattern on CFDS presented the higher sensitivity (83.3%) for malignancy with a specificity of 43.7%. Microcalcifications on US in combination with a type III CFDS pattern showed a lesser sensitivity (80.6%) with an improved specificity (75.4%). In our opinion, the better balanced combination of US and CFDS features was the absence of halo sign plus microcalcifications and a type III CDFS pattern (sensitivity 72.2%, specificity 77.2%). Conclusions: The combination of conventional US and CFDS provides benefits in increasing the screening sensitivity and accuracy in distinguishing malignant thyroid nodules.

1.
Gharib H: Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am 1997;26:777–800.
2.
Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi A: Diagnostic accuracy of conventional versus sonography-guided FNAB of thyroid nodules. Thyroid 1998;8:15–21.
3.
Mortensen JD, Noolner LB, Bennet WA: Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 1955;15:1270–1280.
4.
Maruchi N, Furihata R, Makiuchi M: Population surveys on the prevalence of thyroid cancer in a non-endemic region, Nagano, Japan. Int J Cancer 1971;7:575–583.
5.
Belfiore A, La Rosa GL: Fine needle aspiration biopsy of the thyroid. Endocrinol Metab Clin North Am 2001;30:361–400.
6.
Haugen BR, Woodmansee WW, McDermott MT: Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours. Clin Endocrinol (Oxf) 2002;56:281–290.
7.
Aschcraft MN, Van Herle AJ: Management of thyroid nodules. II: Scanning techniques, thyroid suppressive therapy and fine needle aspiration biopsy. Head Neck Surg 1981;3:297–322.
8.
Khurana K, Richards V, Chopra PS, Izquerdo R: The role of us guided FNAB in management of non palpable thyroid nodules. Thyroid 1998;8:511–514.
9.
Takuya H, Kaoru H, Hiromitsu I, Shigeto I: Evaluation of US-guided FNAB thyroid nodules. Am J Surg 1998;175:133–136.
10.
Multanen M, Haapiainen R, Leppaniemi A,Voutilainen P, Sivula A: The value of US-FNAB and frozen section examination in the diagnosis of thyroid cancer. Ann Chir Gynecol 1999;88:132–135.
11.
Davis LN, Gordon M, German E, Robins E, Mc Gregor IG: Clinical parameters predictive of malignancy of thyroid follicular neoplasms. Am J Surg 1991;161:567–569.
12.
Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK: Diagnosis of ‘follicular neoplasm’: a grey zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002;261:41–44.
13.
Cusik EL, Mac Intosh CA, Krukowski ZH, Williams VMM, Ewens WB, Matheson NA: Management of isolated thyroid swelling: a prospective six years study of fine needle aspiration cytology in diagnosis. Br Med J 1990;301:318–321.
14.
Peccin S, de Castro JA, Furlanetto TW, Furtado AP, Brasil BA, Czepielewski MA: Ultrasonography: is it useful in the diagnosis of cancer in thyroid nodules? J Endocrinol Invest 2002;25:39–43.
15.
Andreoli M, Centanni M, Sciacchitano S, Olivari L: Needle aspiration cytology in the early diagnosis of carcinoma of the thyroid gland: experience with 3045 nodules. Ann Ital Med Int 1987;2:100–109.
16.
Yamamoto Y, Maeda T, Izumi K, Otsuka H: Occult papillary carcinoma of the thyroid. A study of 408 autopsies cases. Cancer 1990;65:1173–1179.
17.
Pisani T, Vecchione A, Sinopoli N, Prusco A, Velli C, Giovagnoli M: Cytological and immunocytological analysis of laterocervical lymph nodes in patients with previous thyroid carcinoma. Anticancer Res 1999;19:3527–3530.
18.
Rago T, Vitti P, Chiovato L, Mazzeo S, De Liperi A, Miccoli P, et al: Role of conventional ultrasonography and colour flow Doppler sonography in predicting malignancy in ‘cold’ thyroid nodules. Eur J Endocrinol 1998;138:41–46.
19.
Braga M, Cavalcanti TC, Colloco LM, Graf H: Efficacy of ultrasound-guided fine-needle aspiration biopsy in the diagnosis of complex thyroid nodules. J Clin Endocrinol Metab 2001;86:4089–4091.
20.
Becker D, Bair HJ, Becker W, Gunter E, Lohner W, Learch S, et al: Thyroid autonomy with colour-coded image-directed Doppler sonography internal hypervascularization for the recognition of autonomous adenoma. J Clin Ultrasound 1997;25:63–69.
21.
Giammarco M, Di Gesu G, Massenti MF, Di Trapani B, Vetri G: Role of colour flow Doppler sonography in pre-operative diagnostics of the thyroid pathology. Minerva Endocrinol 2002;27:1–10.
22.
Anguissola R, Bozzini A, Campani R, Bottinelli O, Genovese E, Guglielmoni B, et al: Ruolo della colour coded duplex sonography nello studio della patologia tiroidea. Radiol Med 1991;81:831–837.
23.
Shimamoto K, Endo T, Ishigaki T, Makino N: Intratumoral blood flow: evaluation with colour-Doppler ultrasonography. Radiology 1987;165:683–685.
24.
Argalia G, D’Ambrosio F, Lucarelli F, Mignosi U, Giuseppetti GM, Passarini G, et al: Echo Doppler in the characterization of the thyroid nodular goitre. Radiol Med 1995;89:651–657.
25.
Hamming JF, Goslings BM, van Steenis GJ, Claasen HR, Hermans J, Velde CJH: The value of fine-needle aspiration biopsy in patients with nodular thyroid disease divided into groups of suspicion of malignant neoplasms on clinical grounds. Arch Intern Med 1990;150:113–116.
26.
Solomon DS: Fine needle aspiration of the thyroid: an uptake. Thyroid Today 1993;16:1–9.
27.
Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, et al: Risk of malignancy in non palpable thyroid nodules: predictive value of ultrasound and colour-Doppler features. J Clin Endocrinol Metab 2002;87:1941–1946.
28.
UICC TNM. Classification of Malignant Tumours, ed 6. New York, Wiley Liss, 2002.
29.
Chan BK, Desser TS, McDougall IR, Weigel RJ, Jeffrey RB Jr: Common and uncommon sonographic features of papillary thyroid carcinoma. J Ultrasound Med 2003;22:1083–1090.
30.
Iannuccilli JD, Cronan JJ, Monchick JM: Risk for malignancy of thyroid nodules as assessed by sonographic criteria. J Ultrasound Med 2004;23:1455–1464.
31.
Kim EK, Park CS, Chung WY, Oh KK, Kim DI, Lee JT, Yoo HS: New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol 2002;178:687–691.
32.
Frates MC, Benson CB, Doubilet PM, Cibas ES, Marqusee E: Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules? J Ultrasound Med 2003;22:127–131.
33.
Nam-Goong IS, Kim HY, Gong G, Lee HK, Hong SJ, Kim WB, Shong YK: Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf) 2004;60:21–28.
34.
Wienke JR, Chong WK, Fielding JR, Zou KH, Mittelstaedt CA: Sonographic features of benign thyroid nodules: interobserver reliability and overlap with malignancy. J Ultrasound Med 2003;22:1027–1031.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.